2024 (1 POST)

Laurer D, Benson S, Marshall L, Wood L, Keeton K, Steigerwald D, Dobyns L, Finley B. Asbestos and laryngeal cancer: A fiber-type specific meta-analysis. Poster presentation at Society of Toxicology 63rd Annual Meeting, Salt Lake City, UT, 2024.

2021 (1 POST)

Ierardi AM, Lotter JT, Jacobs N, Finley BL, Pierce JS. Derivation of a proposed asbestiform tremolite NOAEL for lung cancer. Virtual poster Presentation at Society of Toxicology 60th Annual Meeting, Virtual, 2021.

2019 (2 POSTS)

Towle KM, Riordan AS, Pierce JS, Finley BL, Hollins DM. Exposure to asbestos and risk of ovarian cancer: A systematic literature review and meta-analysis. Poster presentation at American Industrial Hygiene Conference & Exposition (AIHce), Minneapolis, MN, 2019.

Ierardi AM, Urban A, Jacobs NFB, McMenamy C, Finley BL, Gaffney SH. Characterization of airborne asbestos exposures from the use of dental products: A comprehensive review. Poster presentation at American Industrial Hygiene Conference & Exposition (AIHce), Minneapolis, MN, 2019.

2016 (4 POSTS)

Pierce JS, Ruestow PS, Finley BL. An updated evaluation of reported chrysotile asbestos no observed adverse effect levels (NOAELs) for lung cancer and mesothelioma. Poster presentation at American Industrial Hygiene Conference & Exposition (AIHce), 2016.

Pierce JS, Ruestow PS, Finley BL. An updated evaluation of reported chrysotile asbestos no observed adverse effect levels (NOAELs) for lung cancer and mesothelioma. Abstract #2139. Poster presentation at Society of Toxicology 55th Annual Meeting, New Orleans, LA, 2016.

Burns AM, Finley BL. Potential tremolite exposures associated with talc- containing products. Abstract #2672. Poster presentation at Society of Toxicology 55th Annual Meeting, New Orleans, LA, 2016.

Benson SM, Batdorf S, Hitchcock KM, Galbraith DA, Finley BL. Asbestos exposure and pharyngeal and laryngeal cancer risk: A fiber-type specific meta-analysis. Abstract #2974. Poster presentation at Society of Toxicology 55th Annual Meeting, New Orleans, LA, 2016.

2013 (1 POST)

Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE. 2013. Exposures from chrysotile-containing joint compound: Evaluation of new model relating respirable dust to fiber concentrations. Risk Anal 33(1):161-176; doi: 10.1111/j.1539-6924.2012.01847.x.

View Abstract

2012 (4 POSTS)

Phelka AD, Finley BL. 2012. Potential health hazards associated with exposures to asbestos-containing drywall accessory products: A state-of-the-science assessment. Crit Rev Toxicol 42(1):1–27; doi: 10.3109/10408444.2011.613067. PMID: 22044019.

View Abstract

Finley BL, Pierce JS, Paustenbach DJ, Scott LLF, Lievense L, Scott PK, Galbraith DA. 2012. Malignant pleural mesothelioma in U.S. automotive mechanics: Reported vs. expected number of cases from 1975-2007. Regul Toxicol Pharmacol 64(1):14–116; doi: 10.1016/j.yrtph.2012.05.015. PMID: 22668748.

View Abstract

Finley BL, Pierce JS, Phelka AD, Adams RE, Paustenbach DJ, Thuett KA, Barlow CA. 2012. Evaluation of tremolite asbestos exposures associated with the use of commercial products. Crit Rev Toxicol 42(2):119–146. doi: 10.3109/10408444.2011.636028. PMID: 22141364.

View Abstract

Berman DW, Brorby GP, Sheehan PJ, Bogen KT, Holm SE. 2012. More on the dynamics of dust generation: The effects of mixing and sanding chrysotile, calcium carbonate, and other compounds on the characteristics of joint-compound dusts. Ann Occup Hyg 56(7):852-867.

View Abstract

2011 (1 POST)

Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE. 2011. Potential artifacts associated with historical preparation of joint compound samples and reported airborne asbestos concentrations.  J Occup Environ Hyg 8(5):271–278.

View Abstract

2008 (1 POST)

Wagner ME, Travis LB. 2008. Letter to the editor re: “Mesothelioma and asbestos.” Regul Toxicol Pharmacol 52(3):353–354 (author reply, 355).